Suchergebnisse - "Muller, Marcel A"

PubPharm (29)

1

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

enthalten in: Nature communications | 2022

von Fathi, A. | Dahlke, C. | Krähling, V. | +24

2

Cutting Edge : Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2022

von Meyer-Arndt, L. | Schwarz, T. | Loyal, L. | +15

3

Reduced IFN-ß inhibitory activity of Lagos bat virus phosphoproteins in human compared to Eidolon helvum bat cells

enthalten in: PloS one | 2022

von Papies, J. | Sieberg, A. | Ritz, D. | +3

4

Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients : results from a prospective observational study

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Mühlemann, B. | Thibeault, C. | Hillus, D. | +101

5

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

enthalten in: Nature communications | 2021

von Aziz, N. | Corman, V. | Echterhoff, A. | +8

6

SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients

enthalten in: Frontiers in immunology | 2021

von Schwarz, T. | Heiss, K. | Mahendran, Y. | +10

7

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

enthalten in: Emerging infectious diseases | 2020

von Okba, N. | Müller, M. | Li, W. | +16

CommentIn: Infect Control Hosp Epidemiol. 2021 May;42(5):638-639. - PMID 32530392

8

Virological assessment of hospitalized patients with COVID-2019

enthalten in: Nature | 2020

von Wölfel, R. | Corman, V. | Guggemos, W. | +15

CommentIn: Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3438-3439. - PMID 32329812

9

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

enthalten in: Cell | 2020

von Hoffmann, M. | Kleine-Weber, H. | Schroeder, S. | +10

CommentIn: Antimicrob Agents Chemother. 2020 May 21;64(6):. - PMID 32312781

10

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

enthalten in: Frontiers in immunology | 2020

von Schlickeiser, S. | Schwarz, T. | Steiner, S. | +15